A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®

Alfred von Krempelhuber; Jens Vollmar; Rolf Pokorny; Petra Rapp; Niels Wulff; Barbara Petzold; Amanda Handley; Lyn Mateo; Henriette Siersbol; Herwig Kollaritsch; Paul Chaplin

doi:10.1016/j.vaccine.2009.11.030

A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®

Vaccine ◽

10.1016/j.vaccine.2009.11.030 ◽

2010 ◽

Vol 28 (5) ◽

pp. 1209-1216 ◽

Cited By ~ 71

Author(s):

Alfred von Krempelhuber ◽

Jens Vollmar ◽

Rolf Pokorny ◽

Petra Rapp ◽

Niels Wulff ◽

...

Keyword(s):

Phase Ii ◽

Vaccine Candidate ◽

Phase Ii Study ◽

Smallpox Vaccine ◽

Dose Finding ◽

Third Generation ◽

Double Blind ◽

The Third

Download Full-text

Randomized, Double-Blind, Dose-Finding, Phase II Study of Prasugrel in Japanese Patients Undergoing Elective Percutaneous Coronary Intervention

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.26013 ◽

2015 ◽

Vol 22 (6) ◽

pp. 557-569 ◽

Cited By ~ 23

Author(s):

Takeshi Kimura ◽

Takaaki Isshiki ◽

Hisao Ogawa ◽

Hiroyoshi Yokoi ◽

Tetsu Yamaguchi ◽

...

Keyword(s):

Percutaneous Coronary Intervention ◽

Phase Ii ◽

Phase Ii Study ◽

Japanese Patients ◽

Coronary Intervention ◽

Dose Finding ◽

Double Blind ◽

Elective Percutaneous Coronary Intervention ◽

Percutaneous Coronary

Download Full-text

Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-β-1a in moderately active ulcerative colitis

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2008.03778.x ◽

2008 ◽

Vol 28 (6) ◽

pp. 758-767 ◽

Cited By ~ 24

Author(s):

C. PENA-ROSSI ◽

S. SCHREIBER ◽

G. GOLUBOVIC ◽

A. MERTZ-NIELSEN ◽

J. PANES ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Phase Ii ◽

Phase Ii Study ◽

Dose Finding ◽

Active Ulcerative Colitis ◽

Interferon Β ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study

International Urogynecology Journal ◽

10.1007/bf02001083 ◽

1998 ◽

Vol 9 (3) ◽

pp. 145-150 ◽

Cited By ~ 28

Author(s):

E. H. J. Weil ◽

P. H. A. Eerdmans ◽

G. A. Dijkman ◽

K. Tamussino ◽

J. Feyereisl ◽

...

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Phase Ii ◽

Phase Ii Study ◽

Dose Finding ◽

Double Blind ◽

Double Blind Placebo ◽

Moderate Stress

Download Full-text

Faculty of 1000 evaluation for A Double-Blind, Randomized Phase II Study to Evaluate the Safety and Efficacy of Acetyl-L-Carnitine in the Prevention of Sagopilone-Induced Peripheral Neuropathy.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718136956.793486581 ◽

2013 ◽

Author(s):

Steve Plaxe ◽

Kristy Ward

Keyword(s):

Peripheral Neuropathy ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Safety And Efficacy ◽

Randomized Phase Ii

Download Full-text

Faculty Opinions recommendation of Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726641973.793540485 ◽

2017 ◽

Author(s):

Lori Ann Birder

Keyword(s):

Overactive Bladder ◽

Phase Ii ◽

Combination Treatment ◽

Patient Reported Outcomes ◽

Phase Ii Study ◽

Double Blind ◽

Patient Reported ◽

Dose Ranging

Download Full-text

Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimer's Disease

Current Alzheimer Research ◽

10.2174/1567210200438162050 ◽

2010 ◽

Vol 999 (999) ◽

pp. 1-12 ◽

Cited By ~ 2

Author(s):

Gareth Maher-Edwards ◽

Marina Zvartau-Hind ◽

A. Jacqueline Hunter ◽

Michael Gold ◽

Gillian Hopton ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Receptor Antagonist ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind

Download Full-text

A Randomized, Double‐Blind , Placebo‐Controlled , Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study

The Oncologist ◽

10.1634/theoncologist.2020-0679 ◽

2020 ◽

Vol 25 (11) ◽

Author(s):

Richard F. Riedel ◽

Karla V. Ballman ◽

Yao Lu ◽

Steven Attia ◽

Elizabeth T. Loggers ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Refractory

Download Full-text

Dose-Finding of Linaclotide for Patients with Chronic Constipation in Japan: A Phase II Randomized, Double-Blind, and Placebo-Controlled Study

Gastroenterology ◽

10.1016/s0016-5085(17)31900-5 ◽

2017 ◽

Vol 152 (5) ◽

pp. S515-S516

Author(s):

Shin Fukudo ◽

Hiroto Miwa ◽

Atsushi Nakajima ◽

Yoshikazu Kinoshita ◽

Masanori Kosako ◽

...

Keyword(s):

Phase Ii ◽

Chronic Constipation ◽

Dose Finding ◽

Controlled Study ◽

Double Blind

Download Full-text

Updated report: A randomized, double-blind, placebo-controlled phase II study of prophylactic dexamethasone (dex) therapy for fatigue and malaise due to regorafenib in patient (pts) with metastatic colorectal cancer (mCRC): (KSCC1402/HGCSG1402)

Annals of Oncology ◽

10.1093/annonc/mdw370.95 ◽

2016 ◽

Vol 27 ◽

pp. vi180

Author(s):

S. Yuki ◽

Y. Komatsu ◽

H. Satake ◽

Y. Miyamoto ◽

H. Tanioka ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure　– A Randomized, Double-Blind, Placebo-Controlled Phase II Study –

Circulation Journal ◽

10.1253/circj.cj-15-1112 ◽

2016 ◽

Vol 80 (3) ◽

pp. 668-676 ◽

Cited By ~ 18

Author(s):

Hiroyuki Tsutsui ◽

Shinichi Momomura ◽

Akira Yamashina ◽

Hisao Ogawa ◽

Hiroaki Shimokawa ◽

...

Keyword(s):

Heart Failure ◽

Heart Rate ◽

Chronic Heart Failure ◽

Phase Ii ◽

Rate Control ◽

Phase Ii Study ◽

Japanese Patients ◽

Heart Rate Control ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®

Randomized, Double-Blind, Dose-Finding, Phase II Study of Prasugrel in Japanese Patients Undergoing Elective Percutaneous Coronary Intervention

Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-β-1a in moderately active ulcerative colitis

Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study

Faculty of 1000 evaluation for A Double-Blind, Randomized Phase II Study to Evaluate the Safety and Efficacy of Acetyl-L-Carnitine in the Prevention of Sagopilone-Induced Peripheral Neuropathy.

Faculty Opinions recommendation of Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY).

Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimer's Disease

A Randomized, Double‐Blind , Placebo‐Controlled , Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study

Dose-Finding of Linaclotide for Patients with Chronic Constipation in Japan: A Phase II Randomized, Double-Blind, and Placebo-Controlled Study

Updated report: A randomized, double-blind, placebo-controlled phase II study of prophylactic dexamethasone (dex) therapy for fatigue and malaise due to regorafenib in patient (pts) with metastatic colorectal cancer (mCRC): (KSCC1402/HGCSG1402)

Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure – A Randomized, Double-Blind, Placebo-Controlled Phase II Study –

Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure　– A Randomized, Double-Blind, Placebo-Controlled Phase II Study –